RxDoctor Payments Data

Douglas Walker, DO

Family Medicine · Garland, UTNPI 1821095142

Payments from drug & device makers

$3,833in general payments, 2019–2025

Across 222 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$647
  • Johnson & Johnson$570
  • AbbVie$444
  • AstraZeneca$274
  • Amarin Pharma, Inc.$248
  • Merz North America, Inc.$238
  • plus $1K from 32 others

What the payments were for

  • Food & beverage$3,833100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,833 in reported general payments places this provider in the 75th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$61,403
Medicare patients
92
Services billed
909

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin86$97,144
FarxigaDapagliflozin Propanediol58$68,180
OzempicSemaglutide45$63,702
EliquisApixaban40$37,477
MounjaroTirzepatide21$22,396
SymbicortBudesonide/Formoterol Fumarate20$5,717
MyrbetriqMirabegron12$5,311
Tresiba Flextouch U-100Insulin Degludec12$5,109
Omeprazole174$3,766
Pravastatin Sodium273$3,525
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$2,911
Levothyroxine Sodium214$2,057
Lisinopril244$2,053
Dexlansoprazole DrDexlansoprazole12$1,923
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$1,898

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$647$97,14486 claims
AstraZenecaFarxiga, Symbicort$274$73,89778 claims
Novo NordiskOzempic$69$63,70245 claims
PfizerEliquis$131$37,47740 claims
Lilly USA, LLCMounjaro$169$22,39621 claims
Astellas Pharma US IncMyrbetriq$36$5,31112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 928 family medicine providers in Utah.

Other family medicine in Garland

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →